Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Return on Equity (2024 - 2025)

Kura Oncology (KURA) has disclosed Return on Equity for 2 consecutive years, with 1.34% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity fell 93.0% to 1.34% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.34%, a 93.0% decrease, with the full-year FY2025 number at 0.95%, down 52.0% from a year prior.
  • Return on Equity was 1.34% for Q4 2025 at Kura Oncology, down from 0.78% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.11% in Q1 2024 to a low of 1.34% in Q4 2025.